Skip to main content
. Author manuscript; available in PMC: 2014 Feb 5.
Published in final edited form as: Cancer Gene Ther. 2011 Jun 24;18(8):598–608. doi: 10.1038/cgt.2011.30

Figure 1.

Figure 1

Schematic representation of the recombinant measles virus (MV) genomes. Vectors harbor either unmodified hemagglutinin (H) or fully retargeted H against prostate stem cell antigen (PSCA) and CD20 (listed at the bottom, middle), respectively, in combination with the transgene X = enhanced green fluorescent protein (EGFP) or purine nucleoside phosphorylase (PNP) (listed at the bottom, left). Corresponding names of the viruses are listed at the bottom right side.